Travena, Inc. (TRVN) Stock Exhibits Minor Volatility Following First Patient Enrolment in ACTIV-4 Host Tissue Trial
Travena, Inc. (TRVN) stock prices were down 3.24% shortly after market trading commenced on July 27th, 2021, bringing the price per share down to USD$1.3464.